 Dextroamphetamine
Dextroamphetamine
 
																	
																		
																	
																		
																	
																	
																		
																	
																		
																	
																	
																			
																					
	"Dextroamphetamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
    
			
			
				
				
					
						| Descriptor ID | D003913 | 
					
						| MeSH Number(s) | D02.092.471.683.152.110.200 | 
					
						| Concept/Terms | DextroamphetamineDextroamphetaminedextro-Amphetaminedextro AmphetamineDexamphetamined-Amphetamined AmphetamineDexamfetamine
 OxydessOxydessVortech Brand of Dextroamphetamine Sulfate
 Dextroamphetamine SulfateDextroamphetamine SulfateSulfate, Dextroamphetamined-Amphetamine Sulfated Amphetamine SulfateDextro-Amphetamine SulfateDextro Amphetamine Sulfate
 DextroStatDextroStatShire Brand of Dextroamphetamine Sulfate
 CurbanCurbanPasadena Brand of Dextroamphetamine
 DexedrineDexedrineGlaxoSmithKline Brand of Dextroamphetamine SulfateMallinckrodt Brand of Dextroamphetamine SulfateCelltech Brand of Dextroamphetamine Sulfate
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Dextroamphetamine".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Dextroamphetamine".
				
			 
		 
	 
 
																				
																					
	
	
		
			
			
					
				This graph shows the total number of publications written about "Dextroamphetamine" by people in UAMS Profiles by year, and whether "Dextroamphetamine" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2021 | 1 | 0 | 1 | 
| 2017 | 0 | 2 | 2 | 
| 2015 | 1 | 0 | 1 | 
| 2009 | 0 | 1 | 1 | 
| 2008 | 1 | 0 | 1 | 
| 2007 | 1 | 0 | 1 | 
| 2005 | 2 | 0 | 2 | 
| 2004 | 2 | 0 | 2 | 
| 2003 | 2 | 2 | 4 | 
| 2002 | 2 | 0 | 2 | 
| 2001 | 0 | 2 | 2 | 
| 1999 | 0 | 1 | 1 | 
| 1992 | 1 | 0 | 1 | 
| 1991 | 0 | 1 | 1 | 
| 1990 | 0 | 1 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Dextroamphetamine" by people in Profiles over the past ten years.
						
					
								- 
								Thompson RG, Oliveto A, Thostenson JD, Wilson MP, McGaugh J, Mancino MJ. Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial. J Psychopharmacol. 2021 11; 35(11):1420-1430. 
- 
								Berquist MD, Thompson NA, Baker LE. Evaluation of training dose in male Sprague-Dawley rats trained to discriminate 4-methylmethcathinone. Psychopharmacology (Berl). 2017 Nov; 234(21):3271-3278. 
- 
								Berquist MD, Baker LE. Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats. Behav Pharmacol. 2017 08; 28(5):394-400.